Griffonia simplicifolia for pain in healthy volunteers
Part of Pain clinical trials.
This trial tests if a natural supplement called Griffonia simplicifolia can change how your body processes pain. It is looking for healthy people to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are not pregnant or breastfeeding.
- You do not have kidney or liver problems.
- You do not have nerve, skin, or heart conditions.
- You do not have chronic pain or take pain relievers.
- You are not taking antidepressants, sleep aids, MAO inhibitors, or St. John's wort.
- You are not allergic to Griffonia simplicifolia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a supplement called Boswellia serrata (frankincense) can change how your body processes pain and touch. It is for healthy people who do not have chronic pain or use certain medications.
This study tests whether taking specific dietary supplements based on your biomarker results (from a urine sample) can improve quality of life for people with chronic pain. You'll take the supplements daily and report how you're feeling.
This trial tests a full-spectrum cannabis extract (a product containing many cannabis compounds) to see if it helps with chronic pain and affects bone health in women. You will receive either the cannabis extract or a placebo (a dummy pill) in a random order, and neither you nor the study team will know which one you are taking at the time.
This study tests how two pain medications interact when given together. It is for adults with chronic pain (not from cancer) and may help doctors understand how to combine these drugs safely.
This trial studies whether changing the “stimulation pattern” of spinal cord stimulation can reduce long-lasting pain and improve daily function. You might be a good candidate if you have chronic trunk or leg pain and have already tried multiple pain treatments without enough relief.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.